SCHEMBL24072387

SCHEMBL24072387

CC(=O)Nc1ccccc1C(=O)Nc1ncc(N=O)s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.44
▸ POLB P06746 2/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ RAB9A P51151 6/20 0.42
▸ ALDH1A1 P00352 6/20 0.42
▸ NPC1 O15118 5/20 0.42
▸ MEN1 O00255 4/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ MAPT P10636 3/20 0.42
▸ NPSR1 Q6W5P4 3/20 0.42
▸ STAT3 P40763 2/20 0.42
▸ PKM P14618 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ HTT P42858 2/20 0.42
▸ MLNR O43193 1/20 0.42
▸ NR1I2 O75469 1/20 0.42
▸ ABCB11 O95342 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ ADRB2 P07550 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27134415 0.89 RAB9A (0.44) KDM4EPOLBRAB9AALDH1A1NPC1
SCHEMBL24073682 0.88 ALDH1A1 (0.44) KDM4EPOLBRAB9AALDH1A1NPC1
SCHEMBL24073675 0.88 KDM4E (0.43) KDM4EPOLBRAB9AALDH1A1NPC1
SCHEMBL24073667 0.87 CCNE1 (0.44) KDM4EPOLBCYP2C19RAB9AALDH1A1
SCHEMBL27134412 0.86 CCNE1 (0.44) KDM4EPOLBRAB9AALDH1A1NPC1
SCHEMBL24073673 0.86 KDM4E (0.58) KDM4EPOLBRAB9AALDH1A1NPC1
SCHEMBL24072390 0.85 JAK2 (0.47) KDM4EPOLBRAB9AALDH1A1NPC1
SCHEMBL24073688 0.85 STAT3 (0.47) KDM4ERAB9AALDH1A1NPC1MEN1
SCHEMBL27134416 0.84 TSHR (0.51) KDM4EPOLBALDH1A1MEN1KMT2A
SCHEMBL24072309 0.84 MEN1 (0.49) KDM4EPOLBRAB9AALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 — — US disclosed
WO-2021239117-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI) , INC. (CN) 2021-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 KDM4E 786/4885POLB 273/4885CYP2C19 3913/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 KDM4E 786/4885POLB 273/4885CYP2C19 3913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback